Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Information for Health Care Providers

The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a virus that can cause acute respiratory illness. MERS-CoV was first identified in Saudi Arabia in 2012.

The following countries in the Middle East have reported cases of MERS-CoV: Bahrain, Iran, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates and Yemen. The majority of cases have been reported in Saudi Arabia.

Additional cases have been identified in Europe, North Africa, Asia and the United States in people who visited the Middle East or were in close contact with someone who traveled there.

See Public Health Agency of Canada for more information:

Risk to Canadians

The risk to Canadians is low. MERS-CoV does not appear to spread easily from person to person. The primary risk of exposure is present in the affected countries in the Middle East.

Although we do not know exactly how people become infected with MERS-CoV, many people with MERS have had close contact with family members, co-workers, other patients, or health care workers who have been sick with MERS. The importance of following strict infection control practices in health care settings cannot be stressed enough.

MERS-CoV has been found in some camels, and some MERS patients have reported contact with camels or camel-based products (e.g. milk or meat).Camels may play a role in the transmission of the virus in the Middle Eastern countries.

Persons with diabetes, kidney failure, or chronic lung disease and those who have weakened immune systems may be at higher risk of developing severe MERS.

Clinical presentation

Spectrum of illness ranges from mild to severe acute respiratory illness (SARI)./p>

Recommended infection prevention and control measures

Follow the recommendations in Infection Prevention and Control Measures and Initial Management of Persons Who May Be Infected with a Novel Respiratory Virus.

Laboratory testing

Refer to Laboratory Testing for Persons Who May be Infected with a Novel Respiratory Virus.

Patient instructions

Practise hand hygiene and respiratory etiquette, and avoid contact with others while ill.

We need your feedback to improve Help us improve